Description
ImatinibisananticancerchemotherapeuticcompoundthatinhibitsAbl,c-Kit,andPDGFR;itisusedclinicallytotreatPhiladelphiachromosome-positivechronicmyelogenousleukemia(CML)andacutelymphocyticleukemia(ALL).Incellularassays,imatinibaccelerateserythroblastdifferentiationandinhibitsmelanogenesis.
References
WangY,ZhaoY,LiuL,etal.Inhibitoryeffectsofimatinibmesylateonhumanepidermalmelanocytes.ClinExpDermatol.2014Mar;39(2):202-8.PMID:24479586.
D"allardD,GayJ,DescarpentriesC,etal.Tyrosinekinaseinhibitorsinducedown-regulationofc-KitbytargetingtheATPpocket.PLoSOne.2013Apr23;8(4):e60961.PMID:23637779.
Gambacorti-PasseriniCB,GunbyRH,PiazzaR,etal.MolecularmechanismsofresistancetoimatinibinPhiladelphia-chromosome-positiveleukaemias.LancetOncol.2003Feb;4(2):75-85.PMID:12573349.